Track: Central Nervous System

Session Overview:

The Central Nervous System (CNS) plays a pivotal role in controlling and coordinating all bodily functions, serving as the primary hub for processing sensory information and initiating responses. In this session, we will explore cutting-edge research and innovations that are transforming our understanding of CNS disorders, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injuries. Participants will gain insights into neuroplasticity, the brain's remarkable ability to adapt and recover, and how this knowledge is being applied to develop new therapies. The session will also cover advances in neuroimaging techniques that allow for earlier and more accurate diagnoses, as well as novel therapeutic approaches, including gene therapy and neurostimulation. Attendees will have the opportunity to engage with experts in the field, discuss the implications of these developments, and explore the ethical considerations surrounding emerging CNS treatments.

Recent Developments:

Recent advancements in neuroimaging, including high-resolution MRI, are providing unprecedented details of brain structures, enabling earlier detection of neurodegenerative diseases and more precise brain lesion mapping. Functional connectomics is enhancing our understanding of neural pathways, aiding in the study of conditions like autism, schizophrenia, and depression. In gene therapy, CRISPR-Cas9 technology is being applied to edit genes linked to neurological disorders, offering potential cures for conditions like Huntington's disease, while adeno-associated viruses (AAV) are showing promise in treating spinal muscular atrophy. Progress in neuroplasticity includes stem cell therapies for repairing CNS tissue, offering hope for spinal cord injury and stroke patients. Optogenetics is rapidly advancing, providing new insights into brain function and potential therapies for epilepsy and Parkinson's disease. AI-powered diagnostics and machine learning are improving CNS disorder treatments and accelerating drug discovery. Additionally, therapies targeting microglia are reducing neuroinflammation, and wearable neuromodulation devices like TMS and tDCS are being optimized for non-invasive treatment of mental health conditions.

Sub-Tracks:

Neurodegenerative Disorders

Focuses on the mechanisms, early detection, and novel treatments for conditions like Alzheimer’s, Parkinson’s, and Huntington’s diseases.

Neuroplasticity and Repair

Examines the brain's ability to reorganize itself by forming new neural connections and advances in therapies aimed at enhancing recovery after injury.

Neuroinflammation

Investigates the role of inflammation in various CNS disorders, including its impact on disease progression and potential therapeutic strategies.

Neurogenesis

Explores the process of generating new neurons in the brain and its implications for cognitive function and mental health.

Neuroimaging and Diagnostics

Covers the latest advancements in imaging techniques and diagnostic tools that enhance the understanding and treatment of CNS disorders.

Neuropharmacology

The study of drugs and their effects on the nervous system, including mechanisms of action and therapeutic potentials for various CNS disorders.

Neurodevelopmental Disorders

Focuses on conditions that affect brain development, such as autism spectrum disorders, ADHD, and intellectual disabilities.

Neuroscience of Pain

Examines the mechanisms of pain perception and processing, and explores treatments for chronic pain conditions.

Cognitive Neuroscience

Investigates the neural basis of cognitive functions such as memory, attention, and language.

Neuroendocrinology

Studies the interactions between the nervous system and endocrine system, including how hormones affect brain function and behavior.

3rd International Conference on Neurology and Mental Disorders

Track: Central Nervous System

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at